![]() |
市場調査レポート
商品コード
1422077
人工膝関節置換術の世界市場の評価:手術タイプ別、インプラントタイプ別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Knee Replacement Market Assessment, By Procedure Type, By Implant Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
||||||
カスタマイズ可能
|
人工膝関節置換術の世界市場の評価:手術タイプ別、インプラントタイプ別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年02月07日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3~5営業日
|
世界の人工膝関節置換術の市場規模は、2023年の101億米ドルから2031年に153億6,000万米ドルに達し、2024年~2031年の予測期間にCAGRで5.38%の成長が見込まれています。人工膝関節置換術(膝関節形成術とも呼ばれる)は、金属、プラスチック、セラミック製のインプラントを用いて膝の損傷を矯正する外科手術です。これらの手術は、膝の損傷による痛みや苦痛を和らげることを目的としています。関節炎のような加齢に伴う膝疾患により、このような手術を受けるのは高齢者が多いです。
人工膝関節置換術市場は、変形性膝関節症の有病率の増加により成長を示しています。膝の損傷をもっとも受けやすい老年人口の増加が、人工膝関節置換術の需要に拍車をかけています。さらに、低侵襲手術や人工膝関節置換術に使用されるインプラントの技術の進歩が、継続的な市場拡大の傾向を維持しています。世界中での変形性膝関節症と膝に関連する損傷の流行により、人工膝関節置換術の需要が増加しています。人工膝関節置換術は55歳以上の高齢者に多く、世界中での、特に日本や米国のような国々での老年人口の増加が、市場成長をさらに後押ししています。
OECDのデータによると、人口10万人当たりの人工股関節置換術は平均174件、人工膝関節置換術は平均137件行われています。スイス、フィンランドなどの欧州諸国が、OECD加盟国における人工膝関節置換術の件数をリードしています。
変形性膝関節症の高い有病率は、人工膝関節置換術市場の拡大にとって極めて重要です。変形性関節症は骨の関節を侵し、症例のほとんどは膝関節に関連しています。55歳以上と女性は変形性関節症にかかりやすいです。高齢者は骨の変性と滑液の減少により変形性関節症に罹患し、女性はカルシウム不足により罹患します。近年の推計と予測によると、変形性関節症の症例は、予測年間に増加が見込まれています。
例えば、2023年7月に発表されたWHOのファクトシートによると、世界中で5億2,800万人以上が変形性関節症に罹患しており、そのうち約3億6,500万人が膝に関連した症例で、人工膝関節置換術などのソリューションが必要とされています。この5億2,800万人のうち約73%は55歳以上の人々が占めており、その60%は女性です。
インプラント、低侵襲手術、人工膝関節置換術の分野における技術の進歩は、人工膝関節置換術市場の成長に大きく寄与しています。正確な四肢のアライメント、インプラントの位置決め精度の向上、インプラントのサイジングなどの進歩が、患者コンプライアンスを可能にしています。手術用ロボット、AI、3Dプリンティング、コンピューターナビゲーションは、より質の高い人工膝関節置換術の実現に役立つツールの一部です。正確さと精度の必要性が、メーカーを革新的なソリューションの設計へと駆り立て、市場成長をさらに高めています。
例えば、2023年10月、Medacta Group S.A.は、人工膝関節全置換術に適応する世界初の運動学的アライメント最適化大腿骨コンポーネントであるGMK SpheriKAの発売を発表しました。Medacta Group S.A.はスイスを拠点とする企業で、スポーツ医療、人工関節置換術、脊椎手術に向け、個別化された革新的かつ持続可能なソリューションを提供しています。
政府による研究開発への投資は、人工膝関節置換術市場をかなり強化しています。医療機器規制を改革し、人工関節置換術に対する補助金を提供することによる、人工関節置換術のコストを削減することを目的とした政府の取り組みが、市場の成長を大きく後押ししています。さらに、免税措置や有名メーカーとの提携により国内生産が増加し、輸入への依存度が低下しました。これらの措置により、人工膝関節置換術の利用可能性と価格の手頃さが向上し、特定の国が人工膝関節置換術市場の主要国として確立され、医療部門における経済成長と技術革新を促進しています。
例えば、米国政府のComprehensive Care for Joint Replacement(CJR)Modelは、2024年12月に8つの実施年度(PY)を終了する予定です。このプログラムは、股関節、膝関節、足関節の人工関節置換術(下肢人工関節置換術とも呼ばれる)を受ける患者に向けた金融の促進を目的としたMedicare Part AおよびBの決済モデルです。このプログラムは8年にわたり大きな成功を収めており、人工膝関節置換術市場を支援する政府の取り組みの好例となっています。
当レポートでは、世界の人工膝関節置換術市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。
Global knee replacement market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 10.1 billion in 2023 to USD 15.36 billion in 2031. Knee replacement (also known as knee arthroplasty) is a surgical procedure to rectify knee damage using implants made of metal, plastic, or ceramics. These surgeries aim to relieve the pain and suffering caused by knee damage. The elderly population is the major recipient of such surgeries due to age-associated knee problems like arthritis.
The knee replacement market is experiencing growth due to the growing prevalence of osteoarthritis. The rising geriatric population, which is most prone to knee damage, is fueling the demand for knee replacements. Furthermore, technological advances in minimally invasive surgeries and implants used for knee replacements sustain a tendency for continual market expansion. The rising prevalence of osteoarthritis and knee-associated damage across the globe is increasing the demand for more knee replacement surgeries. Knee replacement surgeries are more common in old-age people above the age of 55 years, thus, the growing geriatric population globally and especially in countries like Japan and United States, further propelling the market growth.
As per OECD data, on average 174 hip replacements per 100,000 people, and 137 knee replacements per 100,000 people are being performed. European countries like Switzerland, Finland, and others are leading the number of knee replacements among OECD countries.
The high prevalence of knee-associated osteoarthritis is critical for the expansion of the knee replacement market. Osteoarthritis affects bone joints, and most of the cases are related to knee joints. People over the age of 55 years and female population are highly susceptible to osteoarthritis. The old age population is affected by osteoarthritis due to degenerative bones and reduced synovial fluid while females are affected because of calcium deficiency. As per recent estimates, osteoarthritis cases are expected to grow during the forecasted years.
For instance, according to the WHO factsheet published in July 2023, more than 528 million people are affected by osteoarthritis across the world, out of which around 365 million cases are knee-associated, which requires solutions like knee replacements. Around 73% of these 528 million cases are contributed by the population above the age of 55 years and 60% of these cases belong to female population.
Technological advancements in the field of implants, minimally invasive surgeries, and knee replacement solutions are major contributors to the growth of the knee replacement market. Advancements such as precise limb alignment, improved accuracy in implant positioning, and implant sizing are enabling patient compliance. Surgical robotics, artificial intelligence, 3D printing, and computer navigation are some of the tools that help in achieving better quality knee replacement solutions. The need for accuracy and precision is driving manufacturers to design innovative solutions, further enhancing market growth.
For example, in October 2023, Medacta Group S.A. announced the launch of GMK SpheriKA, which is the world's first kinematic alignment-optimized femoral component indicated for total knee replacement. Medacta Group S.A. is a Switzerland-based company offering personalized, innovative, and sustainable solutions for sports medicine, joint replacement, and spine surgeries.
The government's investment in research and development has considerably enhanced the knee replacement market. Government initiatives aim to reduce the cost of joint replacement surgeries by reforming the medical device regulations and providing subsidies for such surgeries have significantly boosted the market growth. Furthermore, tax exemptions and collaborations with prominent manufacturers have increased domestic output, lowering reliance on imports. These actions have increased the availability and affordability of knee replacement surgeries establishing specific countries as vital players in the knee replacement market, promoting economic growth and technical innovation in the health care sector.
For example, the Comprehensive Care for Joint Replacement (CJR) Model of the United States government is going to complete eight performance years (PYs) in December 2024. The program is a Medicare Part A and B payment model that aims to facilitate finances for patients with hip, knee, and ankle replacements, also called lower extremity joint replacements. The program has been a major success over the course of 8 years and is a good example of government initiatives to support the knee replacement market.
Total knee replacements have established their dominance with strong statistics in the market. Total knee replacement is one of the most effective and cost-efficient procedures for knee surgeries. It is most commonly done for patients suffering from highly painful, end-stage knee arthritis. Market data shows that there is a growing need for total knee replacement procedures owing to the growing geriatric population and decline in nutritional intake. Advancements in robotic-assisted surgeries and implant designing are anticipated to sustain the dominance of the total knee replacement segment within the knee replacement market.
For instance, in February 2023, as per the press release by CK Birla Hospital, Delhi, more than 2.5 lakh total knee replacement surgeries are performed in India every year, and the number has increased almost three times during the last five years.
The knee replacement market is becoming dominant in the North American region. The region is anticipated to dominate the market with the highest value share due to its significant investment in research and development, technical breakthroughs made by major market players, and highly developed healthcare infrastructure in North American countries like the United States and Canada. The market is expanding in the region because of encouraging government initiatives and a favorable reimbursement environment for handling the rising number of surgical procedures. Regulatory approvals and further market expansion are also beneficial to manufacturers. A growing number of knee surgeries is also contributing to the market growth. For instance, the American College of Rheumatology estimates that 790,000 knee operations are performed in the United States each year.
For instance, in April 2023, the USFDA approved the MISHA Knee System, manufactured by Moximed, Inc. for marketing in the United States. MISHA Knee System is an implant placed alongside the knee joint which helps in reducing the weight load and saving knee damage without removing the knee joint.
Growing prevalence of osteoporosis among the geriatric population and females is majorly driving the demand in the knee replacement market.
Rising geriatric population which is more prone to knee damage across the globe is drastically contributing to the knee replacement market.
Total knee replacement is the leading segment in the knee replacement market due to the high demand and volume of surgeries being performed.
Increasing adoption of surgical robotics for knee replacement surgeries as it offers reduced pain, fewer complications, and increased accuracy.
Key participants in the knee replacement market include: Zimmer Biomet Holdings Inc, B. Braun Melsungen AG, Smith & Nephew plc, Stryker Corporation, and Johnson & Johnson Services, Inc. characterizes this landscape, as these companies compete to outperform one another in terms of patient compliance, safety, accuracy, and unique features. The market prognosis remains positive, owing to increased demand for knee replacement surgeries. Knee replacement solution manufacturers are actively involved in designing innovative solutions. Collaborations and modern technologies are projected to increase competition in the market.
In March 2023, Stryker announced the launch of Mako Total Knee 2.0, at the AAOS 2023 annual meeting in Las Vegas. Mako Total Knee 2.0 is unveiled with new features like customizable workflow, intuitive design, innovative digital tensioner that allows surgeons to analyze the knee's stability during total knee arthroplasty without the need for further instrumentation. Mako Total Knee 2.0 has three key components, AccuStop haptic technology, 3D CT-based planning, and insightful data analytics.
In November 2023, Salona Global announced the launch of the Biodex SpaceTek Knee device, which is developed in collaboration with NASA to be used in space as well. Biodex SpaceTek Knee device is a revolutionary portable isokinetic knee dynamometer medical device for treating patients with knee replacements and knee injuries. The FDA approval for the product is still in progress.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.